Myotonic Dystrophy Team Members
Director, Neuromuscular and Myotonic Dystrophy Clinics
Dr. Greene's clinical interests include a wide range of neuromuscular disorders, such as muscular dystrophy, myasthenia gravis, neuropathy, amyotrophic lateral sclerosis (ALS), inflammatory myopathy, and mitochondrial and metabolic myopathy.
Dr. Anderson has special interest in neuromuscular disorders, such as amyotrophic lateral sclerosis (ALS), amyloid neuropathy, myasthenia gravis, and other related disorders.
Dr. Shroff focuses on clinical trials of investigational new drugs for the treatment of myasthenia gravis, muscular dystrophy, amyotrophic lateral sclerosis (ALS) and chronic inflammatory demyelinating polyneuropathy (CIDP).
Dr. Thonhoff's research focuses on the role of regulatory T cells (Tregs) in amyotrophic lateral sclerosis (ALS). The loss of Treg function is associated with the acceleration of disease progression in ALS.
Dr. Mathuria’s clinical interests include atrial fibrillation, biventricular pacing, Watchman, defibrillator implantation, supraventricular tachycardia and ventricular tachycardia. 832.522.8355
Rachel Applegate, BS, CCRC
Patricia Mendoza, RN, CCRC
Social Work Services
Rebecca Axline, LCSW-S, APHSW-C
Julie Schwarz, LCSW
Wendy E. Schell, PT, DPT, MS, CSRS
Pam Glazener, OTR, ATP
Carolyn Martinez, MA, CCC-SLP
Felicia Carter, MA, CCC-SLP
Margaret Farnsworth RD, LD
Dena Furman, RD, LD
Muscular Dystrophy Association